Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy

Area of Science:

• Oncology
• Anesthesiology
• Pain Management

Background:

• Interstitial brachytherapy is a crucial treatment for gynecologic cancers.
• Effective perioperative pain management is essential for patient recovery and timely discharge.

Purpose of the Study:

• To propose an optimal perioperative pain management clinical care pathway for interstitial brachytherapy in gynecologic cancer patients.
• To identify factors associated with postoperative adverse events and delayed discharge.

Main Methods:

• Retrospective review of 23 women undergoing 32 interstitial brachytherapy procedures.
• Analysis of anesthetic types, medications, pain scores, adverse events (PONV, delirium), and discharge delays.
• Statistical analysis of the association between hydromorphone use, PCA settings, and adverse events.

Main Results:

• 91% of patients received epidural infusion with IV or patient-controlled analgesia (PCA) narcotics.
• Postoperative nausea and/or vomiting (PONV) affected 53%, and delirium occurred in 22%.
• Discharge was delayed in 26% of patients, linked to over-sedation and PONV from basal PCA use. Hydromorphone >5mg/24h correlated with PONV (p=0.01).

Conclusions:

• Optimal perioperative management of gynecologic brachytherapy necessitates a multidisciplinary strategy.
• Implementing a standardized anesthesia clinical care pathway can improve patient care.
• Reducing narcotic administration and utilizing patient-directed infusions may minimize side effects and expedite hospital discharge.